Literature DB >> 9821198

Sex cord-stromal and steroid cell tumors of the ovary.

E K Outwater1, B J Wagner, C Mannion, J K McLarney, B Kim.   

Abstract

Gonadal cell types that derive from the coelomic epithelium (sex cords) or mesenchymal cells of the embryonic gonads include granulosa cells, theca cells, fibroblasts, Leydig cells, and Sertoli cells. Ovarian tumors of these cell types are called sex cord-stromal tumors. This group of tumors represents approximately 8% of ovarian neoplasms and affects all age groups. The more common types are granulosa cell tumors (GCTs), fibrothecomas, and Sertoli-Leydig cell tumors. Sex cord-stromal tumors are of interest partly because of their hormonal effects, which are rare for other ovarian neoplasms. These effects include estrogenic effects (pseudoprecocious puberty, endometrial bleeding, endometrial hyperplasia and carcinoma) and virilization. The variety of gross appearances of these tumors, ranging from large multicystic masses to small solid masses, would appear to preclude a specific radiologic diagnosis. However, in many patients, both clinical and radiologic clues can suggest the diagnosis, including predominantly fibrous content at ultrasound or magnetic resonance imaging (fibrothecoma), large hemorrhagic multicystic mass in a child with pseudoprecocious puberty (juvenile GCT), and associated syndromes such as Peutz-Jeghers syndrome (sex cord tumor with annular tubules) or Ollier disease and Maffucci syndrome (juvenile GCT).

Entities:  

Mesh:

Year:  1998        PMID: 9821198     DOI: 10.1148/radiographics.18.6.9821198

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  42 in total

1.  Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.

Authors:  Zhen Yuan; Xiao Huo; Dezhi Jiang; Mei Yu; Dongyan Cao; Huanwen Wu; Keng Shen; Jiaxin Yang; Ying Zhang; Huimei Zhou; Yao Wang
Journal:  Oncologist       Date:  2020-08-11

2.  Comparative evaluation of multidetector CT and MR imaging in the differentiation of adnexal masses.

Authors:  A C Tsili; C Tsampoulas; M Argyropoulou; I Navrozoglou; Y Alamanos; E Paraskevaidis; S C Efremidis
Journal:  Eur Radiol       Date:  2008-01-10       Impact factor: 5.315

Review 3.  Magnetic resonance imaging of pediatric adnexal masses and mimics.

Authors:  Christopher Z Lam; Govind B Chavhan
Journal:  Pediatr Radiol       Date:  2018-08-04

4.  Metformin intake is associated with better survival in ovarian cancer: a case-control study.

Authors:  Sanjeev Kumar; Alexandra Meuter; Prabin Thapa; Carrie Langstraat; Shailendra Giri; Jeremy Chien; Ramandeep Rattan; William Cliby; Viji Shridhar
Journal:  Cancer       Date:  2012-12-03       Impact factor: 6.860

Review 5.  Imaging of pediatric ovarian neoplasms.

Authors:  Monica Epelman; Kudakwashe R Chikwava; Nancy Chauvin; Sabah Servaes
Journal:  Pediatr Radiol       Date:  2011-05-13

6.  Sertoli-stromal cell tumor of the right ovary: radiological-pathological correlation.

Authors:  Toshiko Yamano; Kumiko Ando; Reiichi Ishikura; Norio Nakao; Toshitada Ogasawara
Journal:  Radiat Med       Date:  2006-10

7.  Steroid Cell Tumour of Ovary - A Rare Case Report.

Authors:  Ranjeev Bhagat; Vijay Kumar Bodal; Nishit Gupta; Pooja Garg
Journal:  J Clin Diagn Res       Date:  2016-09-01

8.  Computed tomography and magnetic resonance imaging features of ovarian fibrothecoma.

Authors:  Jingya Chen; Jianhua Wang; Xiao Chen; Yaohui Wang; Zhongqiu Wang; Dake Li
Journal:  Oncol Lett       Date:  2017-05-22       Impact factor: 2.967

9.  Metastatic gastric cancer to the female genital tract.

Authors:  Hiroshi Matsushita; Kazushi Watanabe; Akihiko Wakatsuki
Journal:  Mol Clin Oncol       Date:  2016-09-21

10.  Ovarian sclerosing stromal tumor in a young woman with ectopic pregnancy: clinical, pathological, and immunohistochemical studies.

Authors:  Yan-Fang Liang; Jin-Cheng Zeng; Jian-Bo Ruan; Dong-Ping Kang; Ling-Mei Wang; Can Chen; Jun-Fa Xu
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.